[Analysis of Agranulocytosis Time and Its Influencing Factors in Patients with Hematological Malignancies Treated with rhIL-11 combined rhG-CSF].

Wei, Han-Mei; Li, Zi-Jian; Wang, Li-Na

Wei, Han-Mei; Li, Zi-Jian; Wang, Li-Na.

Affiliation

Wei HM; The First School of Clinical Medicineï¼ The First Hospital of Lanzhou Universityï¼ Lanzhou 730000ï¼ Gansu Province, China.
Li ZJ; Department of Hematologyï¼ The First Hospital of Lanzhou Universityï¼ Lanzhou 730000ï¼ Gansu Province, China,E-mailï¼ldyy_lizj@lzu.edu.cn.
Wang LN; Department of Hematologyï¼ The First Hospital of Lanzhou Universityï¼ Lanzhou 730000ï¼ Gansu Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 30(3): 930-936, 2022 Jun.

Article in Zh | MEDLINE | ID: mdl-35680829

Subject(s)

Agranulocytosis; Hematologic Neoplasms; Lymphoma, Non-Hodgkin; Granulocyte Colony-Stimulating Factor/therapeutic use; Hematologic Neoplasms/drug therapy; Humans; Interleukin-11; Lymphoma, Non-Hodgkin/drug therapy; Recombinant Proteins/therapeutic use; Retrospective Studies

Key words

agranulocytosis time; hematological malignancy; influencing factors; recombinant human granulocyte-colony stimulating factor; recombinant human interleukin-11

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Hematologic Neoplasms / Agranulocytosis Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google